Nobuyuki Abe

Safety and Efficacy of Nasal Application of CpG Oligodeoxynucleotide as a Mucosal Adjuvant

Satoru Kodama, Nobuyuki Abe, Takashi Hirano et al. · The Laryngoscope · 2006 · 29 citations

Nasal Vaccination With CpG Oligodeoxynucleotide Induces Protective Immunity Against Nontypeable <i>Haemophilus influenzae</i> in the Nasopharynx

Nobuyuki Abe, Satoru Kodama, Takashi Hirano et al. · The Laryngoscope · 2006 · 28 citations

Nasal vaccination with P6 outer membrane protein and α-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx

Kenji Noda, Satoru Kodama, Shingo Umemoto et al. · Vaccine · 2010 · 28 citations

Vaccinology, Vaccination, Nasal Vaccination +15

A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx

Satoru Kodama, Takashi Hirano, Kenji Noda et al. · Vaccine · 2010 · 17 citations

Single Nasal Dose, Mucosal Vaccination, Immunology +5

A single nasal dose of CCL20 chemokine induces dendritic cell recruitment and enhances nontypable Haemophilus influenzae-specific immune responses in the nasal mucosa

Satoru Kodama, Nobuyuki Abe, Takashi Hirano et al. · Acta Oto-Laryngologica · 2011 · 14 citations